Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues

Study shows significant improvement in orthopedic healing process Dr. Shai Yarkoni, Company CEO : "Cellect shows promise of ApoGraft™ technology in use for orthopedic indications treated by fat-derived stem cells. Such stem cell enrichment products... Regenerative Medicine, Orthopaedic Cellect Biotechnology, ApoGraft, stem cell
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news